ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma. Kim IS, Cho SY, Yang M, Han S, et al. Anticancer Res 2023;43:1943-1957.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim IS, Cho SY, Yang M, Han S, et al. ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma. Anticancer Res 2023;43:1943-1957.
PMID: 37097701